Sponsor or institution
Clinical trials and research at Arkayli Biopharma, INC.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $1.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
ARK001 topical treatment for infantile hemangioma
A new skin gel called ARK001 is being tested to safely treat infantile hemangioma in babies by delivering medicine directly to the skin.
-
Creating a safer topical treatment for infantile hemangioma
This study is testing a new skin treatment for infantile hemangioma, a common type of tumor in babies, to make it safer and more effective than the current oral medications.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.